Brevibacillus laterosporus: A Probiotic with Important Applications in Crop and Animal Production

Liu, Yucheng; Zai, Xueying; Weng, Guangying; Ma, Xianyong; Deng, Dun

doi:10.3390/microorganisms12030564

Cited by 2 publications

(1 citation statement)

References 63 publications

(110 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Iurlina & Fritz, 2005 ; Panda et al., 2014 ; Sarkar et al., 2002 ). B. laterosporus is also used as a commercial probiotic, human dietary supplement and feed additive (Liu et al., 2023 ; Liu et al., 2024 ; Wang et al., 2022 ). However, the amount of Mpp75Aa1.1 protein consumption by humans and animals through exposure to B. laterosporus has not been established.…”

Section: Assessmentmentioning

confidence: 99%

Assessment of genetically modified maize MON 95275 (application GMFF‐2022‐5890)

Mullins,

Bresson,

Dalmay

et al. 2024

EFS2

View full text Add to dashboard Cite

Genetically modified maize MON 95275 was developed to confer protection to certain coleopteran species. These properties were achieved by introducing the mpp75Aa1.1, vpb4Da2 and DvSnf7 expression cassettes. The molecular characterisation data and bioinformatic analyses reveal similarity to known toxins, which was further assessed. None of the identified differences in the agronomic/phenotypic and compositional characteristics tested between maize MON 95275 and its conventional counterpart needs further assessment. The GMO Panel does not identify safety concerns regarding the toxicity and allergenicity of the Mpp75Aa1.1 and Vpb4Da2 proteins and the DvSnf7 dsRNA and derived siRNAs as expressed in maize MON 95275 and finds no evidence that the genetic modification would change the overall allergenicity of maize MON 95275. In the context of this application, the consumption of food and feed from maize MON 95275 does not represent a nutritional concern in humans and animals. The GMO Panel concludes that maize MON 95275 is as safe as the conventional counterpart and non‐GM maize varieties tested, and no post‐market monitoring of food/feed is considered necessary. In the case of accidental release of maize MON 95275 material into the environment, this would not raise environmental safety concerns. The post‐market environmental monitoring plan and reporting intervals are in line with the intended uses of maize MON 95275. The GMO Panel concludes that maize MON 95275 is as safe as its conventional counterpart and the tested non‐GM maize varieties with respect to potential effects on human and animal health and the environment.

show abstract

Section: Assessmentmentioning

confidence: 99%

Assessment of genetically modified maize MON 95275 (application GMFF‐2022‐5890)

Mullins,

Bresson,

Dalmay

et al. 2024

EFS2

View full text Add to dashboard Cite

show abstract

Intestinal Microbiome Profiles in Broiler Chickens Raised with Different Probiotic Strains

da Silva,

Almeida,

Borsanelli

et al. 2024

Microorganisms

View full text Add to dashboard Cite

The composition of the intestinal microbiota can influence the metabolism and overall functioning of avian organisms. Therefore, the objective of this study was to evaluate the effect of three different probiotics and an antibiotic on the microbiomes of 1.400 male Cobb® broiler raised for 42 days. The experiment was conducted with the following treatments: positive control diet (basal diet + antibiotic); negative control diet (basal diet without antibiotic and without probiotic); basal diet + Normal Avian Gut Flora (NAGF); basal diet + multiple colonizing strain probiotics (MCSPs); and basal diet + non-colonizing single strain probiotics (NCSSPs). The antibiotic (enramycin—antibiotic growth promoter) and probiotics were administered orally during all experiment (1 to 42 days), mixed with broiler feed. To determine the composition of the microbiota, five samples of ileal digesta were collected from 42-day-old chickens of each experimental group. The alpha and beta diversity of the ileal microbiota showed differences between the groups. MCSPs presented greater richness and uniformity compared to the positive control, negative control, and NCSSPs treatments, while the negative control exhibited greater homogeneity among samples than NCSSPs. MCSPs also showed a higher abundance of the genus Enterococcus. There were differences between the groups for low-abundance taxa (<0.5%), with NAGF showing higher levels of Delftia, Brevibacterium, and Bulleidia. In contrast, NCSSPs had a higher abundance of Ochrobactrum, Rhodoplanes, and Nitrospira. It was concluded that the treatments analyzed in this study induced modulations in the ileal microbiota of the chickens examined.

show abstract

Brevibacillus laterosporus: A Probiotic with Important Applications in Crop and Animal Production

Cited by 2 publications

References 63 publications

Assessment of genetically modified maize MON 95275 (application GMFF‐2022‐5890)

Assessment of genetically modified maize MON 95275 (application GMFF‐2022‐5890)

Intestinal Microbiome Profiles in Broiler Chickens Raised with Different Probiotic Strains

Contact Info

Product

Resources

About